Press Releases

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

C-Path Selects Global Regulatory Affairs Leader as New President and CEO

TUCSON, Ariz., March 21, 2019 — After a worldwide search, the Critical Path Institute (C-Path) today announced it has appointed

C-Path, FNIH Announce Clinical Development User’s Guide for Kidney Safety Biomarkers

TUCSON, Ariz., March 14, 2019 — The Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PST

C-Path and FARA Launch Friedreich’s Ataxia Integrated Clinical Database to Advance the Development of Treatments for FA

TUCSON, Ariz. and DOWNINGTOWN, Penn., February 27, 2019 — Critical Path Institute’s (C-Path) Data Collaboration Center (DCC) a

Critical Path Institute Celebrates Expanded Operations with Opening of European Headquarters

C-Path in the EU will work to accelerate the development of new therapies through innovative methodologies for endorsement

Flinn Foundation Awards Critical Path Institute and TGen North a New Grant to Develop and Pilot a System to Respond to Antimicrobial Resistance

TUCSON, Ariz., January 8, 2019 — Critical Path Institute (C-Path) and Flagstaff, Arizona-based TGen North — the Pathogen and M

Critical Path Institute Encouraged by FDA to Move Forward on Type 1 Diabetes Biomarker Initiative

Biomarker potentially could identify individuals at risk of developing T1D TUCSON, Ariz., December 18, 2018 — Critical Path Inst

U.S. Food and Drug Administration Awards Contract to Critical Path Institute for Kidney Transplant Database

Patient-level data will inform the creation of drug development tools and speed development of new immunosuppressive treatments TU

Critical Path Institute Rebrands One of Its First Consortia to Highlight Focus on Alzheimer’s Disease

Critical Path for Alzheimer’s Disease (CPAD) consortium’s refined, refocused mission centers on accelerating therapy developme

C-Path, CHDI and CDISC Announce Therapeutic Area User Guide for Huntington’s Disease

TUCSON, Ariz., NEW YORK and AUSTIN, Texas, November 1, 2018 — The Huntington’s Disease Regulatory Science Consortium (HD-RSC),

FNIH Biomarkers Consortium and Critical Path Institute Achieve the First Ever Qualification of a Clinical Safety Biomarker by the U.S. Food and Drug Administration

Major Milestone will Improve Detection of Drug-Induced Acute Kidney Injury in Clinical Trials. October 25, 2018 —

Previous1718 19...25 Next